Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,774 | 9,325 | 16,564 | 39,215 | 65,064 |
| Marketable Securities | 54,384 | 90,590 | 77,511 | 114,980 | 79,738 |
| Receivables | 8,281 | 11,330 | 14,785 | 17,839 | 7,487 |
| Inventories | 3,570 | 4,770 | 6,157 | 3,258 | 3,666 |
| Other current assets | 2,107 | 283 | 0 | 0 | 2,382 |
| TOTAL | $82,380 | $124,851 | $123,975 | $181,186 | $166,401 |
| Non-Current Assets | |||||
| PPE Net | 544 | 1,911 | 3,001 | 3,320 | 2,616 |
| Intangibles | 19,304 | 20,120 | 110,780 | 41,328 | 34,316 |
| Other Non-Current Assets | 49,208 | 43,418 | 15,521 | 19,648 | 11,748 |
| TOTAL | $69,056 | $65,449 | $129,302 | $64,296 | $48,680 |
| Total Assets | $151,436 | $190,300 | $253,277 | $245,482 | $215,081 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 106 | 111 | 268 | 434 |
| Accounts payable and accrued liabilities | 6,100 | 3,503 | 7,477 | 7,105 | 5,048 |
| Accrued Expenses | 19,810 | 21,695 | 50,926 | 17,222 | 9,308 |
| Other current liabilities | 9,429 | 13,079 | 25,604 | 34,403 | 25,337 |
| TOTAL | $35,984 | $38,383 | $86,539 | $62,421 | $45,248 |
| Non-Current Liabilities | |||||
| Long Term Debt | 121,686 | 115,734 | 156 | 547 | 684 |
| Deferred Revenues | N/A | N/A | 2,007 | 2,223 | 5,121 |
| Other Non-Current Liabilities | 22,965 | 33,403 | 81,002 | 140,445 | 100,015 |
| TOTAL | $144,651 | $149,137 | $81,158 | $140,992 | $100,699 |
| Total Liabilities | $180,635 | $187,520 | $167,697 | $203,413 | $145,947 |
| Shareholders' Equity | |||||
| Common Shares | 429 | 427 | 414 | 414 | 6,331 |
| Retained earnings | -391,215 | -357,989 | -262,685 | -319,800 | -278,524 |
| Other shareholders' equity | -22,804 | -23,414 | -23,627 | -23,565 | -22,657 |
| TOTAL | $-29,199 | $2,780 | $85,580 | $42,069 | $69,134 |
| Total Liabilities And Equity | $151,436 | $190,300 | $253,277 | $245,482 | $215,081 |